Re: Cord blood stem cells cure paralysis (ot)

[Guest guest]

is it really true?

Friday wrote:

Cord blood stem cells cure paralysis

3:23 PM November 28

A South Korean woman paralysed for 20 years is walking again after

scientists repaired her damaged spine using stem cells derived

from

umbilical cord blood.

Hwang Mi-Soon, 37, had been bedridden since damaging her back in

an

accident two decades ago.

South Korean researchers last week went public for the first time

with the results of their stem cell therapy.

Ms Hwang walked into their press conference with the help of a

walking frame.

The researchers say that it is the world's first published case

in

which a patient with spinal cord injuries has been successfully

treated with stem cells from umbilical cord blood.

The researchers caution that more research is needed and verification

from international experts is required but the case could signal

a

leap forward in the treatment of spinal cord injuries.

The use of stem cells from cord blood could also point to a way

to

side-step the ethical dispute over the controversial use of embryos

in embryonic stem cell research.

"We have glimpsed at a silver lining over the horizon," Song Chang-

Hoon, a member of the research team, said.

"We were all surprised at the fast improvements in the patient."

Ms Hwang stood up from her wheelchair and shuffled forward and back

a

few paces with the help of the frame at the press conference.

"This is already a miracle for me," she said. "I never dreamed of

getting to my feet again."

Multipotent cells

Medical research has shown stem cells can develop into replacement

cells for damaged organs or body parts.

Unlocking that potential could see cures for diseases that are at

present incurable, or even see the body generate new organs to

replace damaged or failing ones.

"Multipotent" stem cells, such as those found in cord blood, are

capable of forming a limited number of specialised cell types,

unlike

the more versatile "undifferentiated" cells that are derived from

embryos.

However, these umbilical cord blood stem cells have emerged as an

ethical and safe alternative to embryonic stem cells.

Clinical trials with embryonic stem cells are believed to be years

away because of the risks and ethical problems involved in the

production of embryos, which are regarded as living humans by some

people, for scientific use.

In contrast, there is no ethical dimension when stem cells from

umbilical cord blood are obtained.

Additionally, umbilical cord blood stem cells trigger little immune

response in the recipient.

Embryonic stem cells have a tendency to form tumours when injected

into animals or human beings.

Technical difficulties

For the therapy, multipotent stem cells were isolated from umbilical

cord blood, which had been frozen immediately after the birth of

a

baby and cultured for a period of time.

These cells were then directly injected to the damaged part of the

spinal cord.

"Technical difficulties exist in isolating stem cells from frozen

umbilical cord blood, finding cells with genes matching those of

the

recipient and selecting the right place of the body to deliver

the

cells," Han Hoon, president of government-backed umbilical cord

blood

bank Histostem, said.

Dr Han teamed up with Dr Song and other experts for the experiment.

They say that more experiments are required to verify the outcome

of

the landmark therapy.

"It is just one case and we need more experiments, more data," Oh

Il-

Hoon, another researcher, said.

"I believe experts in other countries have been conducting similar

experiments and accumulating data before making the results public."

- AFP

Source: AFP

[Guest guest]

Where was this article found?

--- In low dose naltrexone , " Friday " <paraschick@y...>

wrote:

>

> Cord blood stem cells cure paralysis

> 3:23 PM November 28

>

> A South Korean woman paralysed for 20 years is walking again after

> scientists repaired her damaged spine using stem cells derived from

> umbilical cord blood.

>

> Hwang Mi-Soon, 37, had been bedridden since damaging her back in an

> accident two decades ago.

>

> South Korean researchers last week went public for the first time

> with the results of their stem cell therapy.

>

> Ms Hwang walked into their press conference with the help of a

> walking frame.

>

> The researchers say that it is the world's first published case in

> which a patient with spinal cord injuries has been successfully

> treated with stem cells from umbilical cord blood.

>

> The researchers caution that more research is needed and

verification

> from international experts is required but the case could signal a

> leap forward in the treatment of spinal cord injuries.

>

> The use of stem cells from cord blood could also point to a way to

> side-step the ethical dispute over the controversial use of embryos

> in embryonic stem cell research.

>

> " We have glimpsed at a silver lining over the horizon, " Song Chang-

> Hoon, a member of the research team, said.

>

> " We were all surprised at the fast improvements in the patient. "

>

> Ms Hwang stood up from her wheelchair and shuffled forward and back

a

> few paces with the help of the frame at the press conference.

>

> " This is already a miracle for me, " she said. " I never dreamed of

> getting to my feet again. "

>

> Multipotent cells

>

> Medical research has shown stem cells can develop into replacement

> cells for damaged organs or body parts.

>

> Unlocking that potential could see cures for diseases that are at

> present incurable, or even see the body generate new organs to

> replace damaged or failing ones.

>

> " Multipotent " stem cells, such as those found in cord blood, are

> capable of forming a limited number of specialised cell types,

unlike

> the more versatile " undifferentiated " cells that are derived from

> embryos.

>

> However, these umbilical cord blood stem cells have emerged as an

> ethical and safe alternative to embryonic stem cells.

>

> Clinical trials with embryonic stem cells are believed to be years

> away because of the risks and ethical problems involved in the

> production of embryos, which are regarded as living humans by some

> people, for scientific use.

>

> In contrast, there is no ethical dimension when stem cells from

> umbilical cord blood are obtained.

>

> Additionally, umbilical cord blood stem cells trigger little immune

> response in the recipient.

>

> Embryonic stem cells have a tendency to form tumours when injected

> into animals or human beings.

>

> Technical difficulties

>

> For the therapy, multipotent stem cells were isolated from

umbilical

> cord blood, which had been frozen immediately after the birth of a

> baby and cultured for a period of time.

>

> These cells were then directly injected to the damaged part of the

> spinal cord.

>

> " Technical difficulties exist in isolating stem cells from frozen

> umbilical cord blood, finding cells with genes matching those of

the

> recipient and selecting the right place of the body to deliver the

> cells, " Han Hoon, president of government-backed umbilical cord

blood

> bank Histostem, said.

>

> Dr Han teamed up with Dr Song and other experts for the experiment.

>

> They say that more experiments are required to verify the outcome

of

> the landmark therapy.

>

> " It is just one case and we need more experiments, more data, " Oh

Il-

> Hoon, another researcher, said.

>

> " I believe experts in other countries have been conducting similar

> experiments and accumulating data before making the results

public. "

>

> - AFP

>

> Source: AFP

[Guest guest]

I think she found it here, AFP

http://www.afp.com/english/afp/?cat=history

adj022762 wrote:

Where was this article found?

--- In low dose naltrexone , "Friday" <paraschick@y...>

wrote:

>

> Cord blood stem cells cure paralysis

> 3:23 PM November 28

>

> A South Korean woman paralysed for 20 years is walking again

after

> scientists repaired her damaged spine using stem cells derived

from

> umbilical cord blood.

>

> Hwang Mi-Soon, 37, had been bedridden since damaging her back

in an

> accident two decades ago.

>

> South Korean researchers last week went public for the first

time

> with the results of their stem cell therapy.

>

> Ms Hwang walked into their press conference with the help of

a

> walking frame.

>

> The researchers say that it is the world's first published case

in

> which a patient with spinal cord injuries has been successfully

> treated with stem cells from umbilical cord blood.

>

> The researchers caution that more research is needed and

verification

> from international experts is required but the case could signal

a

> leap forward in the treatment of spinal cord injuries.

>

> The use of stem cells from cord blood could also point to a way

to

> side-step the ethical dispute over the controversial use of embryos

> in embryonic stem cell research.

>

> "We have glimpsed at a silver lining over the horizon," Song

Chang-

> Hoon, a member of the research team, said.

>

> "We were all surprised at the fast improvements in the patient."

>

> Ms Hwang stood up from her wheelchair and shuffled forward and

back

a

> few paces with the help of the frame at the press conference.

>

> "This is already a miracle for me," she said. "I never dreamed

of

> getting to my feet again."

>

> Multipotent cells

>

> Medical research has shown stem cells can develop into replacement

> cells for damaged organs or body parts.

>

> Unlocking that potential could see cures for diseases that are

at

> present incurable, or even see the body generate new organs to

> replace damaged or failing ones.

>

> "Multipotent" stem cells, such as those found in cord blood,

are

> capable of forming a limited number of specialised cell types,

unlike

> the more versatile "undifferentiated" cells that are derived

from

> embryos.

>

> However, these umbilical cord blood stem cells have emerged as

an

> ethical and safe alternative to embryonic stem cells.

>

> Clinical trials with embryonic stem cells are believed to be

years

> away because of the risks and ethical problems involved in the

> production of embryos, which are regarded as living humans by

some

> people, for scientific use.

>

> In contrast, there is no ethical dimension when stem cells from

> umbilical cord blood are obtained.

>

> Additionally, umbilical cord blood stem cells trigger little

immune

> response in the recipient.

>

> Embryonic stem cells have a tendency to form tumours when injected

> into animals or human beings.

>

> Technical difficulties

>

> For the therapy, multipotent stem cells were isolated from

umbilical

> cord blood, which had been frozen immediately after the birth

of a

> baby and cultured for a period of time.

>

> These cells were then directly injected to the damaged part of

the

> spinal cord.

>

> "Technical difficulties exist in isolating stem cells from frozen

> umbilical cord blood, finding cells with genes matching those

of

the

> recipient and selecting the right place of the body to deliver

the

> cells," Han Hoon, president of government-backed umbilical cord

blood

> bank Histostem, said.

>

> Dr Han teamed up with Dr Song and other experts for the experiment.

>

> They say that more experiments are required to verify the outcome

of

> the landmark therapy.

>

> "It is just one case and we need more experiments, more data,"

Oh

Il-

> Hoon, another researcher, said.

>

> "I believe experts in other countries have been conducting similar

> experiments and accumulating data before making the results

public."

>

> - AFP

>

> Source: AFP

[Guest guest]

Dear adj,

I stumbled on this article in my ISP's homepage under the

banner " Technology News " .

I clicked on the link BILL provided as it states the source of the

news and I didnt find anything there.....

I'm curious about finding the source too now..

Friday

http://www.optusnet.com.au/news/story/abc/20041129/08/tech/1253284.inp

> adj022762 wrote:

>

> >

> > Where was this article found?

> >

[Guest guest]

Thanks

> >

> > >

> > > Where was this article found?

> > >